Bandini, A.; Banchi, M.; Orlandi, P.; Vaglini, F.; Alì, G.; Fontanini, G.; Ottani, A.; Giuliani, D.; Vandini, E.; Francia, G.;
et al. Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo. J. Clin. Med. 2025, 14, 1165.
https://doi.org/10.3390/jcm14041165
AMA Style
Bandini A, Banchi M, Orlandi P, Vaglini F, Alì G, Fontanini G, Ottani A, Giuliani D, Vandini E, Francia G,
et al. Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo. Journal of Clinical Medicine. 2025; 14(4):1165.
https://doi.org/10.3390/jcm14041165
Chicago/Turabian Style
Bandini, Arianna, Marta Banchi, Paola Orlandi, Francesca Vaglini, Greta Alì, Gabriella Fontanini, Alessandra Ottani, Daniela Giuliani, Eleonora Vandini, Giulio Francia,
and et al. 2025. "Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo" Journal of Clinical Medicine 14, no. 4: 1165.
https://doi.org/10.3390/jcm14041165
APA Style
Bandini, A., Banchi, M., Orlandi, P., Vaglini, F., Alì, G., Fontanini, G., Ottani, A., Giuliani, D., Vandini, E., Francia, G., Carli, M., Scarselli, M., & Bocci, G.
(2025). Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo. Journal of Clinical Medicine, 14(4), 1165.
https://doi.org/10.3390/jcm14041165
